A review of CETP and its relation to atherosclerosis.

Journal of Lipid Research
Greetje J de GroothJan Albert Kuivenhoven

Abstract

Although the atheroprotective role of HDL cholesterol (HDL-c) is well documented, effective therapeutics to selectively increase plasma HDL-c levels are not yet available. Recent progress in unraveling human HDL metabolism has fuelled the development of strategies to decrease the incidence and progression of coronary artery disease (CAD) by raising HDL-c. In this quest for novel drugs, cholesteryl ester transfer protein (CETP) represents a pivotal target. The role of this plasma protein in HDL metabolism is highlighted by the discovery that genetic CETP deficiency is the main cause of high HDL-c levels in Asian populations. The use of CETP inhibitors to effectively increase HDL-c concentration in humans was recently published and data with regard to the effect on human atherosclerosis are expected shortly. This review discusses the potential of CETP inhibitors to protect against atherosclerosis in the context of the current knowledge of CETP function in both rodents and humans.

References

Jan 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·N SakaiS Tarui
Apr 1, 1991·The Journal of Clinical Investigation·J D BagdadeP V Subbaiah
May 15, 1989·Biochimica Et Biophysica Acta·M Abbey, G D Calvert
Aug 5, 1988·JAMA : the Journal of the American Medical Association·V ManninenP Koskinen
Mar 1, 1984·The American Journal of Clinical Nutrition·D Applebaum-BowdenW R Hazzard
Jan 17, 1995·Annals of the New York Academy of Sciences·K HiranoY Matsuzawa
Oct 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·R P DullaartA van Tol
Sep 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·R L SeipG Schonfeld
Mar 1, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·J A KuivenhovenP H Pritchard
Sep 22, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·D T AshbyP J Barter
Jul 9, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·S ActonJ M Ordovas
Jul 17, 1999·Atherosclerosis·O Stein, Y Stein

❮ Previous
Next ❯

Citations

Dec 16, 2006·Current Atherosclerosis Reports·James M McKenney, John A Hoekstra
Mar 21, 2009·Human Genetics·Himadri RoySeppo Yla-Herttuala
Feb 3, 2006·Cardiovascular Drugs and Therapy·Michael Schachter
Jan 25, 2007·Nature Clinical Practice. Cardiovascular Medicine·Daniel J Rader
Mar 15, 2006·Nature Reviews. Genetics·Ryan R BrinkmanMark E Samuels
Apr 18, 2006·Journal of Cardiopulmonary Rehabilitation·Danielle Duffy, Daniel J Rader
Jun 16, 2005·Current Opinion in Cardiology·Danielle Duffy, Daniel J Rader
Jan 13, 2006·Current Opinion in Lipidology·Dick C ChanGerald F Watts
Mar 14, 2007·Current Opinion in Lipidology·Dmitri Sviridov, Paul J Nestel
Aug 24, 2012·Science Translational Medicine·Brett LauringAndrew Plump
Nov 15, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Anisa JahangiriFrederick C de Beer
Dec 5, 2006·The Journal of Clinical Investigation·Daniel J Rader
Oct 13, 2011·Lipids in Health and Disease·Hao Wang, Dao-Quan Peng
Nov 29, 2013·Lipids in Health and Disease·Jun WangJian Bin Gong
Mar 14, 2009·Journal of Lipid Research·Laura K PotterFrank L Tobin
Apr 28, 2010·Journal of Lipid Research·Daphna Weissglas-Volkov, Päivi Pajukanta
Jul 17, 2008·Vascular Health and Risk Management·Navin K KapurRoger S Blumenthal
Dec 18, 2008·Pakistan Journal of Biological Sciences : PJBS·Taghi Hassanzadeh GhasabehMax Paoli
Oct 3, 2014·Mediators of Inflammation·Qianqian Miao, Momar Ndao
Jul 16, 2008·Expert Opinion on Therapeutic Targets·Ekaterini Vourvouhaki, George V Dedoussis
Oct 23, 2008·Expert Review of Cardiovascular Therapy·Alan T RemaleyDmitri Sviridov
Dec 24, 2011·Expert Opinion on Investigational Drugs·Amanda J Hooper, John R Burnett
Mar 28, 2008·Expert Opinion on Investigational Drugs·Vasilios G AthyrosDimitri P Mikhailidis
Jun 26, 2012·Expert Opinion on Investigational Drugs·Amanda J Hooper, John R Burnett
Jan 26, 2006·Expert Opinion on Investigational Drugs·Sheila A Doggrell
Jan 30, 2007·Current Medical Research and Opinion·Benjamin Ansell, F D Richard Hobbs
Apr 30, 2013·The Canadian Journal of Cardiology·Jennifer FuRobert A Hegele
Dec 12, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Wanee PlengpanichWeerapan Khovidhunkit
Dec 31, 2011·Clinical Biochemistry·Leonardo D CacciagiúLaura Schreier
Jan 8, 2016·Journal of Human Genetics·Ahmet O ÇağlayanMurat Günel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.